|Bid||0.00 x 800|
|Ask||0.00 x 1000|
|Day's Range||77.07 - 79.83|
|52 Week Range||71.35 - 131.95|
|Beta (5Y Monthly)||0.59|
|PE Ratio (TTM)||18.53|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
In this article you are going to find out whether hedge funds think BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is a good investment right now. We like to check what the smart money thinks first before doing extensive research on a given stock. Although there have been several high profile failed hedge fund picks, the consensus picks […]
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of BioMarin...
BioMarin (BMRN) beats estimates for both earnings and revenues in the first quarter of 2021.